Chandra Bhagat Pharma Limited Stock

Equities

CBPL

INE07QQ01016

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:52 2024-04-25 EDT 5-day change 1st Jan Change
114.8 INR +2.77% Intraday chart for Chandra Bhagat Pharma Limited 0.00% -1.88%

Financials

Sales 2022 942M 11.29M 15.44M Sales 2023 1.2B 14.35M 19.63M Capitalization 732M 8.77M 12M
Net income 2022 7M 83.88K 115K Net income 2023 9M 108K 148K EV / Sales 2022 1.07 x
Net Debt 2022 152M 1.82M 2.49M Net Debt 2023 124M 1.49M 2.03M EV / Sales 2023 0.71 x
P/E ratio 2022
108 x
P/E ratio 2023
80.8 x
Employees 29
Yield 2022 *
-
Yield 2023
-
Free-Float 14.66%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.77%
Current month+20.89%
1 month+20.89%
3 months-2.26%
6 months+7.24%
Current year-1.88%
More quotes
1 week
111.30
Extreme 111.3
114.85
1 month
102.00
Extreme 102
123.80
Current year
80.00
Extreme 80
148.00
1 year
80.00
Extreme 80
160.00
3 years
40.00
Extreme 40
160.00
5 years
30.50
Extreme 30.5
160.00
10 years
30.50
Extreme 30.5
160.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 02-12-31
Director of Finance/CFO 38 17-09-03
Compliance Officer - 22-03-29
Members of the board TitleAgeSince
Director/Board Member 39 04-05-16
Chief Executive Officer 62 02-12-31
Director of Finance/CFO 38 17-09-03
More insiders
Date Price Change Volume
24-04-25 114.8 +2.77% 7,000

Delayed Quote Bombay S.E., April 25, 2024 at 06:00 am

More quotes
Chandra Bhagat Pharma Ltd is an India-based pharmaceutical company. The Company is engaged in the business of marketing pharmaceutical critical care and health care products. The Company is focused on marketing pharmaceutical formulations and products in the domestic and international market through its own distribution network and sales under its own brand. It focuses on Injection - IV (Intravenous) and IM (Intramuscular), tablets and capsules supplied to hospitals and health care center for critical diseases. The Company also deals in importing and supplying active pharmaceutical ingredients (API) and its intermediates. The Company also has its presence in the therapeutic categories for formulations such as anti-cancer (oncology), antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, antifungal, antiviral, pediatrics, cardiology, nephrology, and neurology. It is also engaged in promoting and marketing of API in India.
More about the company